Table 1.

Effects of RSVL treatment (10 mg/kg,i.p.) on the therapeutic action of DOX (15 mg/kg,i.p.) in mice bearing Ehrlich ascites carcinoma cells

Treatment	Mean survival time	45-day survivors
Control	15 ± 4.06 a, b	0/10
RSVL (10 mg/kg)	13 ± 3.55 b	0/10
DOX (15 mg/kg)	21 ± 9.19 a, b	1/10
DOX (15 mg/kg) + RSVL (10 mg/kg) (supplied simultaneously)	30 ± 5.29 a, b	7/10

Each data represents the mean ± S.D. of ten mice. The mean Survival time is the time in days until animals die.

^aSignificantly different from control at P-value ≤ 0.05. ^bSignificantly different from DOX at P-value ≤ 0.05.